AI in the OR: Caresyntax Secures $180 Million for Growth
Merging the digital with the physical – AI applications in healthcare – © Caresyntax
According to a company press release, Caresyntax, a leader in precision surgery, has secured $180 million in a series C extension and growth debt expansion round to further develop its AI-powered platform. The company's software captures and analyzes large volumes of video, audio, images, and other clinical and operational data in and around the operating room (OR). This data is then used to provide real-time insights that improve patient outcomes, resource efficiency, and surgical decision-making. The new investment supports the expansion of its platform, which is already in use in over 3,000 ORs worldwide.
Headquartered in San Francisco and Berlin, Caresyntax is transforming the surgical landscape by integrating AI with real-time data analysis, enhancing patient safety, and operational efficiency. This round of funding highlights the growing recognition and adoption of its technology across the healthcare industry.
Björn von Siemens, CFO and CBO of Caresyntax, emphasized the importance of this investment, stating, "We are grateful for this significant investment in Caresyntax, which strengthens our balance sheet at an important inflection point for the adoption of digital surgery, AI, and automation tools." Notably, Björn von Siemens is the great-great-grandchild of Werner von Siemens, the renowned German electrical engineer who founded Siemens.
The funds will be used to scale customer adoption, enhance AI and cloud applications, and support corporate development opportunities, including mergers and acquisitions. The company’s unique ability to capture and analyze data in real-time has positioned it at the forefront of the $3 trillion global surgical market.
